Get started
Author

Indumathi Kumarathas

Observed name: Kumarathas, Indumathi; id_orcid 0000-0001-9029-1064
ORCID: 0000-0001-9029-1064
Observed ORCID: 0000-0001-9029-1064
OpenAlex ID: A5034071026
The risk of osteoporosis in patients with asthma
2020 · Indumathi Kumarathas, Torben Harsløf, et al. · European Clinical Respiratory Journal · 36
PDF
Reduced Subendocardial Viability Ratio Is Associated With Unfavorable Cardiovascular Risk Profile in Women With Short Duration of Type 2 Diabetes
2016 · Esben Laugesen, Pernille Høyem, et al. · American Journal of Hypertension · 32
Exercise increases myocardial free fatty acid oxidation in subjects with metabolic dysfunction-associated fatty liver disease
2023 · Jeyanthini Risikesan, Sara Heebøll, et al. · Atherosclerosis · 16
PDF
Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
2022 · Sara Heebøll, Jeyanthini Risikesan, et al. · Diabetes · 16
PDF
Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitis
2024 · Jeyanthini Risikesan, Sara Heebøll, et al. · Journal of Lipid Research · 3
PDF
Impaired glucagon-mediated suppression of VLDL-triglyceride secretion in individuals with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
2022 · Sara Heebøll, Jeyanthini Risikesan, et al. · 1
PDF
VLDL-TG and FFA Metabolism in Type 2 Diabetes and metabolic dysfunction-associated steatotic liver disease. Impact of hyperinsulinemia on cardiac and hepatic lipid metabolism and effect of oral high-fat mixed meal tolerance test on hepatic lipid metabolis
2025 · Kumarathas, Indumathi; id_orcid 0000-0001-9029-1064
Impaired glucagon-mediated suppression of VLDL-triglyceride secretion in individuals with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
2022 · Sara Heebøll, Jeyanthini Risikesan, et al.
Works count: 8
Citation count: 104
H-index: 4
I10-index: 4
Year
Topic
Type